Verrica Pharmaceuticals Inc. closed fiscal year 2025 with $47.1M in total assets, $22.4M in total liabilities and $24.7M in shareholder equity. Total assets fell 12.9% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Verrica Pharmaceuticals Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRCA Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-Q | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $47.1M-12.9% | $54.1M-33.7% | $81.6M+82.5% | $44.7M-44.2% | $80.1M+8.1% | $74.2M+8.4% | $68.4M-25.6% | $91.9M+911.8% | $9.1M |
| Total Liabilities | $22.4M-65.0% | $64.0M+3.5% | $61.8M+1219.0% | $4.7M-90.1% | $47.5M+15.4% | $41.2M+1107.6% | $3.4M+37.6% | $2.5M-84.6% | $16.1M |
| Total Equity | $24.7Mn/m | -$9.9M-149.9% | $19.8M-50.6% | $40.0M+22.8% | $32.6M-1.2% | $33.0M-49.3% | $65.0M-27.3% | $89.4Mn/m | -$7.0M |
VRCA Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'25Filing | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $39.9M-2.5% | $36.0M-7.9% | $38.8M-8.0% | $47.1M-12.9% | $40.9M+24.2% | $39.1M-24.8% | $42.2M-36.4% | $54.1M-33.7% | $32.9M-66.1% | $52.0M-16.4% | $66.3M-3.4% | $81.6M+82.5% |
| Total Liabilities | $45.8M-20.9% | $31.7M-44.0% | $22.7M-62.6% | $22.4M-65.0% | $57.9M-13.5% | $56.6M-13.4% | $60.8M-6.2% | $64.0M+3.5% | $67.0M+22.1% | $65.3M+860.3% | $64.8M+1608.4% | $61.8M+1219.0% |
| Total Equity | -$6.0Mn/m | $4.3Mn/m | $16.1Mn/m | $24.7Mn/m | -$17.0Mn/m | -$17.5Mn/m | -$18.6M-1331.8% | -$9.9M-149.9% | -$34.1M-180.5% | -$13.3M-124.0% | $1.5M-97.7% | $19.8M-50.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Verrica Pharmaceuticals Inc. financials
Frequently Asked Questions
Verrica Pharmaceuticals Inc. closed fiscal year 2025 with $47.1M in total assets, $22.4M in total liabilities and $24.7M in shareholder equity.
Verrica Pharmaceuticals Inc. (VRCA) total assets fell by 12.9% year over year, from $54.1M to $47.1M in fiscal year 2025.
Across the 9 fiscal years this page covers, Verrica Pharmaceuticals Inc. (VRCA) total assets went from $9.1M in fiscal year 2017 to $47.1M in fiscal year 2025.
Verrica Pharmaceuticals Inc. (VRCA) reported $39.9M in total assets in Q3 2026. This represents a decrease of 2.5% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Verrica Pharmaceuticals Inc. (VRCA) reported on that line in every period on record.